PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NTNX vs. RXST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NTNX and RXST is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

NTNX vs. RXST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nutanix, Inc. (NTNX) and RxSight, Inc. (RXST). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%SeptemberOctoberNovemberDecember2025February
41.57%
-34.87%
NTNX
RXST

Key characteristics

Sharpe Ratio

NTNX:

0.52

RXST:

-0.63

Sortino Ratio

NTNX:

1.01

RXST:

-0.70

Omega Ratio

NTNX:

1.15

RXST:

0.92

Calmar Ratio

NTNX:

0.66

RXST:

-0.57

Martin Ratio

NTNX:

1.46

RXST:

-1.21

Ulcer Index

NTNX:

16.92%

RXST:

25.11%

Daily Std Dev

NTNX:

47.65%

RXST:

48.64%

Max Drawdown

NTNX:

-80.40%

RXST:

-53.21%

Current Drawdown

NTNX:

-3.87%

RXST:

-48.61%

Fundamentals

Market Cap

NTNX:

$18.90B

RXST:

$1.33B

EPS

NTNX:

-$0.34

RXST:

-$0.81

Total Revenue (TTM)

NTNX:

$1.66B

RXST:

$109.81M

Gross Profit (TTM)

NTNX:

$1.42B

RXST:

$70.16M

EBITDA (TTM)

NTNX:

$99.46M

RXST:

-$18.36M

Returns By Period

In the year-to-date period, NTNX achieves a 15.28% return, which is significantly higher than RXST's -3.90% return.


NTNX

YTD

15.28%

1M

13.01%

6M

41.57%

1Y

20.34%

5Y*

15.08%

10Y*

N/A

RXST

YTD

-3.90%

1M

-4.23%

6M

-34.87%

1Y

-32.49%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NTNX vs. RXST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NTNX
The Risk-Adjusted Performance Rank of NTNX is 6363
Overall Rank
The Sharpe Ratio Rank of NTNX is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of NTNX is 5858
Sortino Ratio Rank
The Omega Ratio Rank of NTNX is 6060
Omega Ratio Rank
The Calmar Ratio Rank of NTNX is 7171
Calmar Ratio Rank
The Martin Ratio Rank of NTNX is 6262
Martin Ratio Rank

RXST
The Risk-Adjusted Performance Rank of RXST is 1515
Overall Rank
The Sharpe Ratio Rank of RXST is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of RXST is 1616
Sortino Ratio Rank
The Omega Ratio Rank of RXST is 1717
Omega Ratio Rank
The Calmar Ratio Rank of RXST is 1313
Calmar Ratio Rank
The Martin Ratio Rank of RXST is 1414
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NTNX vs. RXST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Nutanix, Inc. (NTNX) and RxSight, Inc. (RXST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NTNX, currently valued at 0.52, compared to the broader market-2.000.002.004.000.52-0.63
The chart of Sortino ratio for NTNX, currently valued at 1.01, compared to the broader market-4.00-2.000.002.004.001.01-0.70
The chart of Omega ratio for NTNX, currently valued at 1.15, compared to the broader market0.501.001.502.001.150.92
The chart of Calmar ratio for NTNX, currently valued at 0.66, compared to the broader market0.002.004.006.000.66-0.57
The chart of Martin ratio for NTNX, currently valued at 1.46, compared to the broader market-30.00-20.00-10.000.0010.0020.0030.001.46-1.21
NTNX
RXST

The current NTNX Sharpe Ratio is 0.52, which is higher than the RXST Sharpe Ratio of -0.63. The chart below compares the historical Sharpe Ratios of NTNX and RXST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.52
-0.63
NTNX
RXST

Dividends

NTNX vs. RXST - Dividend Comparison

Neither NTNX nor RXST has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NTNX vs. RXST - Drawdown Comparison

The maximum NTNX drawdown since its inception was -80.40%, which is greater than RXST's maximum drawdown of -53.21%. Use the drawdown chart below to compare losses from any high point for NTNX and RXST. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-3.87%
-48.61%
NTNX
RXST

Volatility

NTNX vs. RXST - Volatility Comparison

The current volatility for Nutanix, Inc. (NTNX) is 10.89%, while RxSight, Inc. (RXST) has a volatility of 13.33%. This indicates that NTNX experiences smaller price fluctuations and is considered to be less risky than RXST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
10.89%
13.33%
NTNX
RXST

Financials

NTNX vs. RXST - Financials Comparison

This section allows you to compare key financial metrics between Nutanix, Inc. and RxSight, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab